Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Guardian pharmacy...

    Guardian pharmacy sells majority stake to Business family Taparias

    Written by kanchan joshi joshi Published On 2016-08-27T09:12:50+05:30  |  Updated On 27 Aug 2016 9:12 AM IST
    Guardian pharmacy sells majority stake to Business family Taparias
    Mumbai: The guardian pharmacy, India’s third largest pharmacy chain after the Apollo and the Medplus has sold its majority stake to the Business family, Taparias. The deal, which had been under consideration few months has come for a consideration of Rs 55 crore, sources told Economic Times.

    Taparias have bought the shares held by Samara Capital and Japan’s Mitsui.

    Samara Capital and Alay Lal a private equity professional are the equity holders in the Guardian pharmacy. After the deal, the guardian pharmacy will be run by a team of professional management. This Pharmacy chain was started in 2003 by Ashutosh Garg who will now have minority stake and will be one of the board of directors in the new company. His interest is expected to be Rs 300 crore in the company, a previous
    TOI
    report suggests.

    It is said that the Guardian will now focus on consolidating itself to NCR and gradually plan for expansion across the country. Guardian will also work on its online arm for pharmacy and health care services.

    Of late, disputes between Samara and Ashutosh Garg were noticed over payment defaults by the Guardian pharmacy to another firms backed by Samara Capital. Samara wanted to step back and had filed a winding up case against the Guardian Lifecare, on the contrary Garg had blamed the private equity firm of illegally removing him from the active management.However, ET adds that both the parties later withdrew all court cases on each other and the matter was resolved.

    Taparias, last year sold its main business, Famycare, the female contraceptive manufacturing companyto a drug maker Mylan for Rs 4600 crore.

    Ashutosh GargGuardianguardian pharmacyhealth newspharmacies IndiaTaparia’s
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    kanchan joshi joshi
    kanchan joshi joshi
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok